ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1696

Measuring Quality Improvement from CME Participants: Results from the RAPID® CME Initiative

Stephen Bender1, Michael Weinblatt2 and Daniel Duch1, 1FACTORx, Cherry Hill, NJ, 2Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2020

Keywords: education, medical, Measurement, Outcome measures, Quality Indicators, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 9, 2020

Session Title: Professional Education Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Medical claims data have been used since 2008 to measure the implementation of the diagnostic and referral strategies resulting from participation in RAPID® CME activities. Since its inception, over 69,782 clinicians have completed at least one RAPID® CME activity. We have reported statistically significant improvements in the participants’ diagnostic and referral performance (Bender S, et al. CE Measure, 2016;10:10-15). While measuring diagnostic and referral patterns is critical to the success of the initiative, the claims database is limited in its ability to provide objective measures in other areas that the RAPID® curriculum addresses. Therefore, an electronic medical record analysis was used to determine the curriculum’s effectiveness in improving clinician’s performance of quality measures associated with rheumatoid arthritis (RA): smoking cessation counseling, cardiovascular (CV) risk, tuberculosis (TB) testing, influenza and other vaccination strategies.

Methods: A retrospective medical record review of recruited providers’ patients was conducted for 23 primary care providers (PCP) meeting the study’s inclusion criteria. To be included in the study, CME participants needed to be a primary care provider currently managing RA patients interested in improving the quality of the care of their RA patients. In order to assess effectiveness of CME on the use of quality measures and patient care, a two-part chart review (pre/post) was conducted with same data compared from random samples of providers’ patients. The target population was defined as all patients, who received a diagnosis of RA, that were being treated by participants of the CME activities. Baseline reviews of 202 random charts from 23 PCPs were examined and compared on follow up with 198 charts from 21 of the same providers who also had participated in baseline chart examination. Patient inclusion criteria included: RA patients >18 years of age; RA ICD–10 codes present; and patients should be seen at least once/year. The quality measures were: Care plan; preventive care and screening; Pneumonia Vaccination Status for Older Adults; Pain Assessment and Follow-Up; falls plan of care; TB screening; tobacco use screening; screening for high blood pressure and follow-up documented; TB Prevention for pso, PsA and RA Patients on a Biological Immune Response Modifier.

Results: Statistically significant improvements were observed for five of the nine quality measures. Measures reaching statistical significance included: Care plan (9.39% Pre/24.29% Post/P-value < 0.0001); preventive care and screening (24.83% Pre/30.14% Post/P-value 0.0422); Pain Assessment and Follow-Up (3.66% Pre/6.59% Post/P-value 0.0096); high blood pressure screening and follow-up (86.1% Pre/94.9% Post/P-value < 0.0001); TB Prevention for pso, PsA and RA Patients on a Biological Immune Response Modifier (1.41% Pre/5.33% Post/P-value 0.0126).

Conclusion: A CME initiative improved clinical performance of learners that will lead to improved care and outcomes for RA patients. While limited in its ability to reach a large number of clinicians, use of electronic medical record data is a useful tool for assessing performance change.


Disclosure: S. Bender, None; M. Weinblatt, Crescendo Bioscience, 1, Bristol Myers Squibb, 1, Sanofi, 2, Lilly, 1, Amgen, 1, AbbVie, 5, Amgen, 2, 5, Arena, 5, Bristol Myers Squibb, 2, 5, Canfite, 1, 5, Corrona, 5, Crescendo, 2, 5, GlaxoSmithKline, 5, Gilead, 9, Horizon, 9, Johnson and Johnson, 9, Lilly, 2, 9, Pfizer, 9, Scipher, 1, 9, Set Point, 9, Roche, 9, Canfite, 1, Inmedix, 1, Lycera, 1, Vorso, 1, Scipher, 1; D. Duch, None.

To cite this abstract in AMA style:

Bender S, Weinblatt M, Duch D. Measuring Quality Improvement from CME Participants: Results from the RAPID® CME Initiative [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/measuring-quality-improvement-from-cme-participants-results-from-the-rapid-cme-initiative/. Accessed February 28, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measuring-quality-improvement-from-cme-participants-results-from-the-rapid-cme-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.